| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fafa1eec9c00865dd0732f384b54452 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2304 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y115-01001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate |
2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15cefc2b536f601945eee9a8c0a298b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0467a5cbcef5d76ac5a1b7c2c3122b96 |
| publicationDate |
2014-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014065096-A1 |
| titleOfInvention |
Cancer therapy by ex vivo activated autologous immune cells |
| abstract |
Disclosed are therapeutic methods for ex-vivo activation of immune cells from a cancer patient for the purpose of inducing tumor regression and/or suppressing metastasis and/or tumor recurrence. In one embodiment mononuclear cells of a patient are isolated from peripheral blood and activated by a combination of innate immune system activators together with means allowing for T cell activation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018144597-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016145292-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019145956-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101594403-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150106190-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017020922-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109069478-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547761-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3466422-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110178-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10675358-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114107202-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11305017-B2 |
| priorityDate |
2012-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |